253 related articles for article (PubMed ID: 29530332)
1. Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: A systematic review and meta-analysis.
Yi L; Zhang H; Zou J; Luo P; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):612-619. PubMed ID: 29530332
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: a systematic review and meta-analysis.
Jingjing H; Rui J; Hui P
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):833-840. PubMed ID: 30720192
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I-III: A Systematic Review and Network Meta-Analysis.
Ao M; Ding T; Tang D; Xi M
Med Sci Monit; 2020 Sep; 26():e925595. PubMed ID: 32950998
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
Li M; Hu M; Wang Y; Yang X
Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():1-6. PubMed ID: 31082737
[TBL] [Abstract][Full Text] [Related]
6. Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer.
Gannavarapu BS; Hrycushko B; Jia X; Albuquerque K
Brachytherapy; 2020; 19(2):139-145. PubMed ID: 32061534
[TBL] [Abstract][Full Text] [Related]
7. SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.
Kahramanoglu I; Meydanli MM; Taranenka S; Ayhan A; Salman C; Sanci M; Demirkiran F; Ortac F; Haidopoulos D; Sukhin V; Kaidarova D; Stepanyan A; Farazaneh F; Aliyev S; Ulrikh E; Kurdiani D; Yalcin İ; Mavrichev S; Akilli H; Sarı ME; Pletnev A; Aslan K; Bese T; Kairbayev M; Vlachos D; Gultekin M
Int J Gynecol Cancer; 2019 Oct; 29(8):1271-1279. PubMed ID: 31481453
[TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
Datta NR; Stutz E; Liu M; Rogers S; Klingbiel D; Siebenhüner A; Singh S; Bodis S
Gynecol Oncol; 2017 May; 145(2):374-385. PubMed ID: 28188016
[TBL] [Abstract][Full Text] [Related]
9. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
[TBL] [Abstract][Full Text] [Related]
10. Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
Guo Q; Wang R; Jin D; Yin Z; Hu B; Li R; Wu D
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):15-23. PubMed ID: 35181028
[TBL] [Abstract][Full Text] [Related]
11. The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care.
Boothe D; Williams N; Odei B; Poppe MM; Werner TL; Suneja G; Gaffney DK
Int J Gynecol Cancer; 2017 Jun; 27(5):912-922. PubMed ID: 28498257
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study.
Albuquerque K; Folkert M; Mayadev J; Christie A; Liotta MR; Nagel C; Sevak P; Harkenrider MM; Lea JS; Hanna RK; Small WC; Miller DS; Xie XJ; Potkul RK; Elshaikh MA
Am J Clin Oncol; 2018 Aug; 41(8):792-796. PubMed ID: 28225446
[TBL] [Abstract][Full Text] [Related]
13. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
[TBL] [Abstract][Full Text] [Related]
15. Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy.
Kim HJ; Lee J; Lee KB; Sung K; Kim YB; Kim YS
Gynecol Oncol; 2024 Mar; 182():39-44. PubMed ID: 38246045
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.
Kong A; Johnson N; Kitchener HC; Lawrie TA
J Natl Cancer Inst; 2012 Nov; 104(21):1625-34. PubMed ID: 22962693
[TBL] [Abstract][Full Text] [Related]
17. Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.
Binder PS; Kuroki LM; Zhao P; Cusworth S; Divine LM; Hagemann AR; McCourt CK; Thaker PH; Powell MA; Mutch DG; Massad LS
Gynecol Oncol; 2017 Nov; 147(2):309-314. PubMed ID: 28916118
[TBL] [Abstract][Full Text] [Related]
18. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
19. Does cytoreductive surgery followed by adjuvant chemo-radiotherapy decrease the risk of recurrence and death in stage III endometrial cancer?
Verrengia A; Sigismondi C; Iannacone E; Bellia A; Busci L; Trezzi G; Malandrino C; Gianatti A; Frigerio L
Tumori; 2020 Aug; 106(4):319-324. PubMed ID: 32008470
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis.
Winarto H; Ibrahim NAA; Putri YM; Adnan FDSF; Safitri ED
PeerJ; 2022; 10():e14420. PubMed ID: 36438578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]